Related Experiment Video
Updated: May 26, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Medication literacy scale for patients with chronic constipation
Hiroko Takaki1, Akihito Hagihara2, Daisuke Kobayashi3
1Clinical Pharmacy and Pharmaceutical Care Education Center, School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Background:
Chronic constipation (CC) is a common gastrointestinal disorder. The disease-specific medication literacy (ML) of people with CC should be assessed because appropriately managing laxatives requires professional guidance, and patients must be able to understand and manage medications. The aim in this study was to develop a Medication Literacy Scale for Patients with Chronic Constipation (MLS-PCC) and evaluate the validity in accordance with the Consensus-based Standards for the selection of health measurement instruments guidelines.
Methods:
The MLS-PCC was developed through item generation and qualitative pilot surveys, followed by quantitative pilot surveys to evaluate content validity. An online cross-sectional survey was then administered to 423 adults with CC in Japan. The structural validity was evaluated using exploratory and confirmatory factor analyses. Between-group differences in the total and subscale scores were examined.
Results:
The final MLS-PCC comprised nine items within three factors-functional, interactive, and critical subscales. The fit of the model was good (CFI = 0.98, TLI = 0.96, and RMSEA = 0.058), with satisfactory reliability (ω = 0.84 for the total scale). The ML scores were substantially higher for women, those with a higher education level, those with gastrointestinal comorbidities, those receiving care in specialty departments, and those taking new laxative prescriptions.
Conclusions:
The content and structural validity of the MLS-PCC were high; the MLS-PCC can serve as a practical tool for assessing ML among patients with CC. The MLS-PCC may support pharmacists and other healthcare professionals in optimizing patient education, enhancing communication, and promoting safe and effective medication use.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
